Key Takeaways
- • Competing Bids in Motion: Veritas Capital has submitted a firm offer of 940 pence per share (932.8p cash plus 7.2p interim dividend) valuing Bodycote at approximately £1.85bn debt-inclusive, while CVC Capital Partners is actively considering a counter-offer after being outbid at 915p per share on August 5.
- • Significant Premiums: Veritas's offer represents a 37.5% premium to Bodycote's three-month volume-weighted average share price as of May 21 and a 42.5% premium to the 12-month average, indicating strong valuation momentum in the competitive process.
- • Strategic Asset at Stake: Bodycote is the world's largest provider of heat treatment and specialist thermal processing, operating approximately 130 facilities across 22 countries with around 4,000 employees, making it a key industrial asset in the aerospace and engineering sectors.
- • Deal Timeline and Completion: If approved by shareholders and cleared by regulators, the transaction is expected to complete in the first quarter of 2027, with the Bodycote board currently recommending the Veritas offer to shareholders.
- • Competitive Tension Maintained: CVC has explicitly urged Bodycote shareholders to take no action pending its own announcement, signaling an active auction process with multiple heavyweight private equity bidders vying for control.
Summary
CVC Capital Partners is evaluating a counter-offer to Veritas Capital's firm proposal to acquire Bodycote plc, the world's leading provider of heat treatment and specialist thermal processing services. Veritas, a New York-based private equity firm managing approximately $54bn in assets and specializing in industrial acquisitions, has tabled an offer of 940 pence per share—comprising 932.8p in cash plus a 7.2p interim dividend—valuing the transaction at roughly £1.85bn on a debt-inclusive basis. This represents a significant step-up from CVC's prior bid of 915p per share, which was surpassed when Veritas announced its firm offer on August 5, 2026.
The Veritas offer commands substantial premiums relative to Bodycote's historical trading valuations. At 940p per share, the bid reflects a 37.5% premium to the three-month volume-weighted average share price through May 21 and a 42.5% premium to the 12-month average. These multiples underscore the competitive dynamics at play and the strategic value the industrial engineering asset commands among premier global acquirers. Bodycote's operational footprint—130 facilities spanning 22 countries with approximately 4,000 employees—positions it as a critical player in aerospace, automotive, and industrial manufacturing supply chains.
CVC's measured response signals an active auction process. Through its subsidiary CVC Advisers, the firm stated it is "considering its position" and will make "a further announcement when appropriate," while simultaneously advising Bodycote shareholders to "take no action in response to the Veritas Offer in the meantime." This positioning preserves CVC's optionality while maintaining negotiating leverage. The competitive tension was reinforced earlier in the process when Apollo Global Management withdrew an unsolicited approach in May, clearing the field for the current two-horse race between Veritas and CVC.
Bodycote's board has recommended the Veritas offer to shareholders, though the company appears to have run parallel negotiating tracks with both suitors, a tactic that has historically extracted value from bidders. The transaction timeline contemplates shareholder approval and regulatory clearance, with expected completion in the first quarter of 2027. The continuing jockeying between CVC and Veritas suggests final valuation outcomes remain fluid and may exceed current levels if a genuine counter-bid emerges.
The Veritas offer commands substantial premiums relative to Bodycote's historical trading valuations. At 940p per share, the bid reflects a 37.5% premium to the three-month volume-weighted average share price through May 21 and a 42.5% premium to the 12-month average. These multiples underscore the competitive dynamics at play and the strategic value the industrial engineering asset commands among premier global acquirers. Bodycote's operational footprint—130 facilities spanning 22 countries with approximately 4,000 employees—positions it as a critical player in aerospace, automotive, and industrial manufacturing supply chains.
CVC's measured response signals an active auction process. Through its subsidiary CVC Advisers, the firm stated it is "considering its position" and will make "a further announcement when appropriate," while simultaneously advising Bodycote shareholders to "take no action in response to the Veritas Offer in the meantime." This positioning preserves CVC's optionality while maintaining negotiating leverage. The competitive tension was reinforced earlier in the process when Apollo Global Management withdrew an unsolicited approach in May, clearing the field for the current two-horse race between Veritas and CVC.
Bodycote's board has recommended the Veritas offer to shareholders, though the company appears to have run parallel negotiating tracks with both suitors, a tactic that has historically extracted value from bidders. The transaction timeline contemplates shareholder approval and regulatory clearance, with expected completion in the first quarter of 2027. The continuing jockeying between CVC and Veritas suggests final valuation outcomes remain fluid and may exceed current levels if a genuine counter-bid emerges.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.